Przegląd preparatów fibrynowych bogatych w płytki krwi

Przegląd preparatów fibrynowych bogatych w płytki krwi

Dostęp do tego artykułu jest płatny.
Zapraszamy do zakupu!

Cena: 6.15 PLN (z VAT)

Po dokonaniu zakupu artykuł w postaci pliku PDF prześlemy bezpośrednio pod twój adres e-mail.

Kup artykuł
MS 2020; 9: 54-57.
Jacek Michał Nowak, Marcin Adamiec, Bartłomiej Iwańczyk, Maciej Rafał Czerniuk

Streszczenie
Preparaty krwiopochodne drugiej generacji – preparaty fibrynowe bogate w płytki krwi znajdują coraz szersze zastosowanie w medycynie. Rośnie również liczba rodzajów tych preparatów, różniąca się protokołem ich przygotowania. Praca ma na celu przybliżenie różnic między nimi, a także usystematyzowanie wiedzy o preparatach  fibrynowych bogatych w płytki krwi.

Abstract
Second-generation blood products – platelet-rich fibrin preparations are increasingly used in medicine. The number of types of these products is also growing, differing in the protocol of their preparation. The aim of this study is to approximate the differences between them, as well as to systematize knowledge of platelet-rich fibrin preparations .

Słowa kluczowe: fibryna bogatopłytkowa, czynniki wzrostu, koncentrat płytkowy
Key words: platelet-rich fibrin, tissue engineering, growth factor level, thrombocyte concentrate

Piśmiennictwo

  1. Alves R, Grimalt R. A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification. Skin Appendage Disord. 2018;4(1):18-24.
  2. Miron RJ, Zucchelli G, Pikos MA, Salama M, Lee S, Guillemette V, et al. Use of platelet-rich fibrin in regenerative dentistry: a systematic review. Clin Oral Investig. 2017;21(6):1913-27.
  3. Dragonas P, Schiavo JH, Avila-Ortiz G, Palaiologou A, Katsaros T. Plasma rich in growth factors (PRGF) in intraoral bone grafting procedures: A systematic review. J Craniomaxillofac Surg. 2019;47(3):443-53.
  4. Ghanaati S, Booms P, Orlowska A, Kubesch A, Lorenz J, Rutkowski J, et al. Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells. J Oral Implantol. 2014;40(6):679-89.
  5. Kobayashi E, Fluckiger L, Fujioka-Kobayashi M, Sawada K, Sculean A, Schaller B, et al. Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clin Oral Investig. 2016;20(9):2353-60.
  6. Dragonas P, Katsaros T, Avila-Ortiz G, Chambrone L, Schiavo JH, Palaiologou A. Effects of leukocyte-platelet-rich fibrin (L-PRF) in different intraoral bone grafting procedures: a systematic review. Int J Oral Maxillofac Surg. 2019;48(2):250-62.
  7. Pirpir C, Yilmaz O, Candirli C, Balaban E. Evaluation of effectiveness of concentrated growth factor on osseointegration. Int J Implant Dent. 2017;3(1):7.
  8. Steller D, Herbst N, Pries R, Juhl D, Hakim SG. Impact of incubation method on the release of growth factors in non-Ca(2+)-activated PRP, Ca(2+)-activated PRP, PRF and A-PRF. J Craniomaxillofac Surg. 2019;47(2):365-72.
  9. Rasmussen J, Ruggeri C, Ciraolo C, Baccanelli M, Yampolsky C, Ajler P. Application of Fibrin Rich in Leukocytes and Platelets in the Reconstruction of Endoscopic Approaches to the Skull Base. World Neurosurg. 2018;118:32-41.
  10. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(3):e45-50.
  11. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27(3):158-67.
  12. Dohan Ehrenfest DM, Pinto NR, Pereda A, Jimenez P, Corso MD, Kang BS, et al. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane. Platelets. 2018;29(2):171-84.
  13. Miron RJ, Fujioka-Kobayashi M, Hernandez M, Kandalam U, Zhang Y, Ghanaati S, et al. Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry? Clin Oral Investig. 2017;21(8):2619-27.
  14. Kobayashi M, Kawase T, Horimizu M, Okuda K, Wolff LF, Yoshie H. A proposed protocol for the standardized preparation of PRF membranes for clinical use. Biologicals. 2012;40(5):323-9.
  15. Tunali M, Ozdemir H, Kucukodaci Z, Akman S, Firatli E. In vivo evaluation of titanium-prepared platelet-rich fibrin (T-PRF): a new platelet concentrate. Br J Oral Maxillofac Surg. 2013;51(5):438-43.
  16. Tunali M, Ozdemir H, Kucukodaci Z, Akman S, Yaprak E, Toker H, et al. A novel platelet concentrate: titanium-prepared platelet-rich fibrin. Biomed Res Int. 2014;2014:209548.
  17. Al-Hamed FS, Tawfik MA-M, Abdelfadil E. Clinical effects of platelet-rich fibrin (PRF) following surgical extraction of lower third molar. The Saudi Journal for Dental Research. 2017;8(1-2):19-25.
  18. Kim TH, Kim SH, Sandor GK, Kim YD. Comparison of platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and concentrated growth factor (CGF) in rabbit-skull defect healing. Arch Oral Biol. 2014;59(5):550-8.
  19. Marenzi G, Riccitiello F, Tia M, di Lauro A, Sammartino G. Influence of Leukocyte- and Platelet-Rich Fibrin (L-PRF) in the Healing of Simple Postextraction Sockets: A Split-Mouth Study. Biomed Res Int. 2015;2015:369273.
  20. Afat IM, Akdogan ET, Gonul O. Effects of Leukocyte- and Platelet-Rich Fibrin Alone and Combined With Hyaluronic Acid on Pain, Edema, and Trismus After Surgical Extraction of Impacted Mandibular Third Molars. J Oral Maxillofac Surg. 2018;76(5):926-32.
  21. Kumar YR, Mohanty S, Verma M, Kaur RR, Bhatia P, Kumar VR, et al. Platelet-rich fibrin: the benefits. Br J Oral Maxillofac Surg. 2016;54(1):57-61.
  22. Caymaz MG, Uyanik LO. Comparison of the effect of advanced platelet-rich fibrin and leukocyte- and platelet-rich fibrin on outcomes after removal of impacted mandibular third molar: A randomized split-mouth study. Niger J Clin Pract. 2019;22(4):546-52.
  23. Ritto FG, Pimentel T, Canellas JVS, Junger B, Cruz M, Medeiros PJ. Randomized double-blind clinical trial evaluation of bone healing after third molar surgery with the use of leukocyte- and platelet-rich fibrin. Int J Oral Maxillofac Surg. 2019;48(8):1088-93.